Skip to main content
Premium Trial:

Request an Annual Quote

Life Biosystems Licenses Fraunhofer Software

NEW YORK (GenomeWeb News) – The German biomedical software company Life Biosystems has licensed entity recognition software from the Fraunhofer Institute for Algorithms and Scientific Computing, and the parties will work together to develop clinical research algorithms.
The ProMiner software covered under the agreement is used for named entity recognition in, biology, medicine, and chemistry, Life Biosystems said.
The collaboration will aim to identify and develop models of therapeutically relevant clinical and lexical information, and will emphasize a drug’s mode of action and the clinical outcome.
Life Biosystems Director of In Silico Discovery David Jackson said that the collaboration will help the company “efficiently bridge the gap between the clinical and molecular information domains,” which could allow innovations in analysis and application of derived data.
"The collaboration with Life Biosystems fits perfectly with our overall strategy to further develop our text-mining technologies for application areas beyond biology” said Julian Fluck, who is head of the text mining group at Fraunhofer SCAI.
Financial terms of the agreement were not released.

Filed under

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.